Beyond CI Teams: A Strategic Intelligence Platform Guide for Pharma R&D, BD, and Biotech Leaders
December 23, 2024
Kognitic's Neural Network Models to Predict Clinical Trial Completion
Kognitic's Neural Network Models to Predict Clinical Trial Completion
Kognitic’s AI-powered neural network model is revolutionizing clinical trial planning. A new study published in Foresight shows that Kognitic’s model reduces the typical 508-day deviation in predicting primary completion dates (PCD) to just 179 days, helping pharmaceutical companies save millions in development costs. By analyzing over 60,000 oncology trials, Kognitic provides data-driven insights that enable more accurate timeline predictions, improving resource planning and reducing costly delays.
Key Findings:
- Reduces PCD prediction error from 508 days to 179 days, enhancing resource planning and cost management
- Analyzes over 60,000 oncology trials to provide precise insights for trial design and execution
- Empowers pharmaceutical companies to avoid costly delays and optimize market entry timing and budget allocation
With planning for 2025 underway, now is the perfect time for CI, R&D, BD, and Commercial teams to integrate Kognitic’s predictive model into their strategies. Start 2025 with more informed decision-making and streamlined clinical trial planning.
Want to see how Kognitic can transform your clinical trial planning?
Book a demo today!
Kognitic’s AI-powered neural network model is revolutionizing clinical trial planning. A new study published in Foresight shows that Kognitic’s model reduces the typical 508-day deviation in predicting primary completion dates (PCD) to just 179 days, helping pharmaceutical companies save millions in development costs. By analyzing over 60,000 oncology trials, Kognitic provides data-driven insights that enable more accurate timeline predictions, improving resource planning and reducing costly delays.
Key Findings:
- Reduces PCD prediction error from 508 days to 179 days, enhancing resource planning and cost management
- Analyzes over 60,000 oncology trials to provide precise insights for trial design and execution
- Empowers pharmaceutical companies to avoid costly delays and optimize market entry timing and budget allocation
With planning for 2025 underway, now is the perfect time for CI, R&D, BD, and Commercial teams to integrate Kognitic’s predictive model into their strategies. Start 2025 with more informed decision-making and streamlined clinical trial planning.
Want to see how Kognitic can transform your clinical trial planning?
Book a demo today!
This material originally appeared in Foresight, 76 (2025:Q1) (forecasters.org/foresight) and is made available with permission of Foresight and the International Institute of Forecasters.
